Figure 7
From: Hepatic and HSC-specific sorafenib effects in rats with established secondary biliary cirrhosis
(a) Small DNA fragments in liver tissue of solvent- and sorafenib-treated BDL rats. Shown is a representative experiment with n=3 rats per group, from experiments with a total of n=6. (b) Hepatic mRNA expression of MCP-1 in solvent- and sorafenib-treated BDL rats. Shown are results from RT-PCR experiments (n=4–8 for each group).
